Anti-BCMA CAR-T cell therapy for refractory / relapsed multiple myeloma: clinical experience of a center
Objective. To evaluate the clinical efficacy of anti-BCMA CAR-T cells in patients with refractory / recurrent multiple myeloma (RRMM.) Materials and methods. Six patients with multiple myeloma MM who had undergone significant pretreatment got anti-BCMA (B-Cell Maturation Antigen) CAR-T (Chimeric An...